Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326636 · ClinicalTrials.gov registry record
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 37
- Enrollment target
NCT02326636: Completed study, sponsored by University of California, Irvine.
NCT02326636 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02326636 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.
Interventions
- BIOLOGICAL Fecal Microbial Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-10-26 |
What the finished NCT02326636 record still lists
NCT02326636 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbial Transplantation is the first listed.
NCT02326636 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02326636 about?
NCT02326636 is a clinical study titled "Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection". The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy o...
What is the current status of trial NCT02326636?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2014-04. Estimated completion is 2018-10-26.
What interventions are being tested in trial NCT02326636?
The interventions under investigation include: Fecal Microbial Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT02326636?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia